Literature DB >> 10923928

Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy.

S Cattan1, D Wendum, O Chazouilleres, J Schmitz, J P Gendre.   

Abstract

A 22-year-old woman without predisposing liver disease developed focal hepatic glycogenosis and hepatocellular carcinoma after 6 years of azathioprine therapy for Crohn's disease. Hepatocellular carcinoma without cirrhosis has previously been described during immunosuppression, but this is the first report of disseminated focal hepatic glycogenosis after long-term azathioprine therapy.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10923928     DOI： 10.1053/hupa.2000.7629

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


  9 in total

1.  Azathioprine induced liver injury: a case report.

Authors:  Narendra S Choudhary; Sachin Gupta; Yogesh K Chawla; Ajay Duseja; Radha K Dhiman; Ashim Das
Journal:  Dig Dis Sci       Date:  2012-04-22       Impact factor: 3.199

2.  Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine.

Authors:  Jason Samarasena; Mark Borgaonkar
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

3.  Hepatocellular carcinoma occurring in a Crohn's disease patient.

Authors:  Mitsuaki Ishida; Shigeyuki Naka; Hisanori Shiomi; Tomoyuki Tsujikawa; Akira Andoh; Tamio Nakahara; Yasuharu Saito; Yoshimasa Kurumi; Mikiko Takikita-Suzuki; Fumiyoshi Kojima; Machiko Hotta; Tohru Tani; Yoshihide Fujiyama; Hidetoshi Okabe
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

4.  Development of hepatocellular carcinoma following treatment with 6-mercaptopurine for ulcerative colitis: investigation of chromosomal aberration by comparative genomic hybridization.

Authors:  Kentaro Nakao; Akira Tsunoda; Yoshinori Shimizu; Koji Takenaka; Koji Morohara; Naoto Suzuki; Katsuo Yamazaki; Takeshi Aoki; Mitsunori Hoshino; Mitsuo Kusano; Eri Kitadai; Toshikazu Kurihara; Yoshiaki Takeuchi; Michio Imawari
Journal:  Int J Clin Oncol       Date:  2005-08       Impact factor: 3.402

5.  Glycogenotic hepatocellular carcinoma with glycogen-ground-glass hepatocytes: a heuristically highly relevant phenotype.

Authors:  Peter Bannasch
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

6.  Hepatocellular carcinoma occurring in a patient with Crohn's disease treated with both azathioprine and infliximab.

Authors:  Shawn C Chen; Oscar W Cummings; Michael P Hartley; Carol A Filomena; Won Kyoo Cho
Journal:  Dig Dis Sci       Date:  2006-05-03       Impact factor: 3.199

Review 7.  [Hepatocellular carcinoma in the non-cirrhotic liver].

Authors:  M Evert; F Dombrowski
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

8.  Metastatic hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine and infliximab: a case report and literature review.

Authors:  Kyle J Fortinsky; Ali Alali; Khursheed Jeejeebhoy; Sandra Fischer; Morris Sherman; Scott Fung
Journal:  Case Rep Gastrointest Med       Date:  2014-12-22

9.  Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?

Authors:  Youssef Botros; Mary Mathews; Hiren Patel; Nihar Shah; Walid Baddoura; Andrew de la Torre
Journal:  Case Rep Gastrointest Med       Date:  2015-12-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.